Recent events
Recent events tied to this brand in public sources.
Back to profile6 entries
2021
Prenosis and Roche Diagnostics expand sepsis diagnostics partnership
Prenosis announced an expansion of its existing partnership with Roche Diagnostics, valued at close to $6 million. The companies will expand the NOSIS dataset and work together to seek FDA clearance for the Prenosis Sepsis Immunoscore and Roche Elecsys IL-6 Assay.
2021
Aster DM Healthcare signs partnership with Roche Diagnostics
Aster DM Healthcare signed a memorandum of understanding with Roche Diagnostics, making Roche Diagnostics its strategic partner across the UAE, Saudi Arabia, Qatar and Oman. The agreement includes antibody COVID-19 testing, digital solutions and automated laboratory solutions.
2021
FDA approves Roche Diagnostics MMR-deficiency test
In a separate regulatory decision, the FDA approved a Roche Diagnostics test that identifies mismatch repair deficiency.
2020
Babyscripts and Roche Diagnostics announce commercial partnership
Babyscripts announced a commercial partnership with Roche Diagnostics to collaborate on digital and diagnostic solutions in women's health, including development of Babyscripts' remote patient monitoring programs for pregnancy.
2020
Nimble Therapeutics and Roche Diagnostics announce collaboration on SARS-CoV-2 diagnostic compounds
Nimble Therapeutics announced a collaboration with Roche Diagnostics to discover peptide-based molecules for developing SARS-CoV-2 in vitro diagnostic assays. Nimble will provide its peptide synthesis, screening, and optimization platform, while Roche will develop the assays.
2020
Inotrem enters worldwide licensing agreement with Roche Diagnostics
Inotrem announced that it entered a worldwide licensing agreement with Roche Diagnostics for commercialization of a mechanism-based companion diagnostic test using soluble plasma protein sTREM-1.